Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New registry aims to map childhood cancer in africa

NCT ID NCT03803735

Knowledge-focused Sponsor: French Africa Pediatric Oncology Group Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating a registry to collect information about children under 18 who are treated for cancer at participating hospitals in Africa. The goal is to track how many children have cancer, what types and stages they have, what treatments they receive, and how they do over time. This data will help health authorities plan better cancer programs for children in the region.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 10,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2016

Expected to finish

Dec 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All childre with any pediatric cancer types, coming into any one of the participating units in a 12 month period.

Ages

1 day to 18 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Any child presenting at any one of the participating units for treatment 2. Any child with any type of cancer 3. Any child or adolescent less than 18 years of age. Exclusion Criteria: 1. No cancer found 2. Age greater than 18 years -

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pediatric cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

childhood malignant neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pediatric cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    14 sites in 12 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Gabriel Touré (HGT)

    RECRUITING

    Bamako, Mali

  • CHU Sylvanus Olympio

    RECRUITING

    Lomé, BP 57, Togo

  • CHU de Treichville à ABIDJAN

    RECRUITING

    Abidjan, Abidjan Autonomous District, Côte d’Ivoire

  • CNLC, Centre National de Lutte contre le Cancer

    RECRUITING

    Niamey, Niger

  • Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle

    RECRUITING

    Ouagadougou, Burkina Faso

  • Centre Mère et Enfant CME-FCB (Fondation Chantal Biya)

    RECRUITING

    Yaoundé, Cameroon

  • Centre National d'Oncologie (CNO)

    RECRUITING

    Nouakchott, Mauritania

  • Cliniques Universitaires de Kinshasa

    RECRUITING

    Kinshasa, Kinshasa City, BP 12 KIN XI, Democratic Republic of the Congo

  • Cliniques Universitaires de Lubumbashi (CUL)

    RECRUITING

    Lubumbashi, BP 1825, Democratic Republic of the Congo

  • GFAOP

    RECRUITING

    Villejuif, PARIS, 00094, France

  • HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona

    RECRUITING

    Antananarivo, Ampefiloha, BP 4150, Madagascar

  • Hopital Yalgado Ouedraogo

    RECRUITING

    Ouagadougou, 03 BP 7022, Burkina Faso

  • Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001

    RECRUITING

    Dakar, Dakar, Senegal

  • l'Institut de Cancérologie de Libreville

    RECRUITING

    Libreville, Gabon

More trials for these conditions

Other studies related to the condition(s) this trial covers.